Profile data is unavailable for this security.
About the company
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
- Revenue in CNY (TTM)106.52m
- Net income in CNY-467.10m
- Incorporated2012
- Employees205.00
- LocationShanghai MicuRx Pharmaceutical Co LtdSHANGHAI 201210ChinaCHN
- Phone+86 2 150900550
- Fax+86 2 161101898
- Websitehttp://www.micurxchina.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.71bn | -9.06m | 2.84bn | 5.51k | -- | 0.948 | -- | 1.05 | -0.0114 | -0.0114 | 3.42 | 3.79 | 0.56 | 1.47 | 11.26 | 491,815.10 | -0.4457 | 0.8618 | -0.6067 | 1.17 | 66.49 | 74.87 | -0.7958 | 1.45 | 1.32 | 1.67 | 0.2392 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Beijing Hotgen Biotech Co Ltd | 454.44m | -26.45m | 2.86bn | 1.04k | -- | 0.8439 | -- | 6.29 | -0.3093 | -0.3093 | 5.14 | 36.65 | 0.1264 | 1.64 | 6.32 | 438,645.70 | -1.04 | 29.65 | -1.11 | 34.70 | 50.71 | 56.08 | -8.25 | 32.26 | 5.50 | -- | 0.0027 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
Chemclin Diagnostics Co Ltd | 455.80m | 150.93m | 2.92bn | 731.00 | 19.37 | 2.11 | -- | 6.42 | 0.3764 | 0.3764 | 1.14 | 3.45 | 0.2684 | 1.02 | 17.03 | 623,526.50 | 8.89 | 11.01 | 9.82 | 12.32 | 74.73 | 74.19 | 33.11 | 31.07 | 5.09 | -- | 0.1518 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 106.52m | -467.10m | 2.95bn | 205.00 | -- | 3.97 | -- | 27.68 | -0.7129 | -0.7129 | 0.1626 | 1.13 | 0.0839 | 0.5802 | 5.74 | 519,588.20 | -36.81 | -- | -40.09 | -- | 81.75 | -- | -438.53 | -- | 6.94 | -- | 0.2497 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
Hinova Pharmaceuticals Inc | 0.00 | -266.00m | 3.00bn | 179.00 | -- | 2.26 | -- | -- | -2.69 | -2.69 | 0.00 | 13.39 | 0.00 | 105.68 | -- | 0.00 | -17.03 | -31.86 | -18.39 | -37.18 | -- | -- | -- | -25,578.24 | 11.83 | -- | 0.0097 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
Bide Pharmatech Co Ltd | 1.10bn | 98.72m | 3.01bn | 846.00 | 30.44 | 1.47 | -- | 2.73 | 1.09 | 1.09 | 12.14 | 22.50 | 0.4585 | 1.09 | 4.76 | 1,302,686.00 | 4.06 | -- | 4.62 | -- | 38.38 | -- | 8.86 | -- | 5.29 | -- | 0.0416 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
Shanghai ZJ Bio-Tech Co Ltd | 241.21m | -115.98m | 3.01bn | 305.00 | -- | 0.7749 | -- | 12.50 | -0.6443 | -0.6443 | 1.26 | 19.98 | 0.0563 | 0.2057 | 1.59 | 790,860.40 | -2.71 | 17.08 | -2.87 | 19.18 | 67.55 | 60.21 | -48.08 | 34.13 | 14.96 | -- | 0.0016 | 34.15 | -88.21 | 4.10 | -118.00 | -- | 35.93 | -- |
Hangzhou Biotest Biotech Co Ltd | 474.05m | 134.34m | 3.04bn | 629.00 | 22.47 | 1.24 | -- | 6.42 | 1.27 | 1.27 | 4.48 | 23.08 | 0.1788 | 2.17 | 8.38 | 753,658.60 | 5.03 | 29.45 | 5.32 | 33.30 | 49.40 | 56.83 | 28.13 | 41.59 | 13.02 | -- | 0.0009 | 29.32 | -76.75 | 19.65 | -86.22 | 41.33 | 34.82 | -- |
Data as of Jun 03 2024. Currency figures normalised to Shanghai MicuRx Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 13.89m | 4.02% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 3.23m | 0.94% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.24m | 0.65% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.89m | 0.55% |
Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 463.13k | 0.13% |
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 449.10k | 0.13% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 295.58k | 0.09% |
Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 292.30k | 0.09% |
CPIC Fund Management Co. Ltd.as of 31 Dec 2023 | 276.79k | 0.08% |
Nuode Asset Management Co., Ltd.as of 31 Dec 2023 | 250.00k | 0.07% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.